Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 5 | $200,924 |
Sells | 2 | $5,057 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Aug 2024 17:23 | GANX | Gain Therapeutics Inc | MACK GENE | CFO and Interim CEO | 09 Aug 2024 | Purchase | 14,400 | 1.01 | 14,544 | D |
12 Aug 2024 17:23 | GANX | Gain Therapeutics Inc | ISLAM KHALID | Executive Chairman | 09 Aug 2024 | Purchase | 50,000 | 0.9988 | 49,940 | D |
01 Jul 2024 17:00 | GANX | Gain Therapeutics Inc | RICHMAN ERIC I | Director | 01 Jul 2024 | Purchase | 12,000 | 1.21 | 14,520 | D |
01 Jul 2024 17:00 | GANX | Gain Therapeutics Inc | RICHMAN ERIC I | Director | 01 Jul 2024 | Purchase | 5,000 | 1.23 | 6,150 | D |
01 Apr 2024 16:01 | GANX | Gain Therapeutics Inc | RILEY JEFFREY SCOTT | Director | 28 Mar 2024 | Purchase | 30,000 | 3.859 | 115,770 | D |
22 Dec 2023 16:17 | GANX | Gain Therapeutics Inc | ALDER MATTHIAS | Chief Executive Officer | 21 Dec 2023 | Sale | 206 | 2.46 | 507 | D |
14 Dec 2023 16:01 | GANX | Gain Therapeutics Inc | ALDER MATTHIAS | Chief Executive Officer | 07 Dec 2023 | Sale | 1,820 | 2.5 | 4,550 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)